clinical trial · NCT06716801
Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain
Aziende Chimiche Riunite Angelini Francesco S.p.A·—·recruiting·n = 300
Focal Epilepsy With and Without Secondary GeneralizationCenobamate
brief summary
Aim of the study is to better characterize the clinical profile of adjunctive cenobamate by collecting data from the current standard clinical practice in France, Germany, and Spain, to describe the real-world clinical response among adult patients affected by focal epilepsy not adequately controlled despite a history of 2 or 3 ASMs before starting treatment with cenobamate (including previous and concomitant ASMs).
started
Dec 19, 2024
primary completion
Mar 1, 2027
completion
Mar 1, 2027
last updated
Sep 19, 2025
official title
Observational Cohort Study on Adult Patients With Not-adequately Controlled FOcal-onset Seizures Treated With Cenobamate as Early adjUnctive Therapy in a Real-world Setting - FOCUS
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol